Xemed LLC   Report issue

For profit Phase 1 Phase 2
Founded: Durham NH United States (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2011
NCT02163681
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Xemed LLC

Active Ingredients

Drugs in Phase 2 Trials (1)

xenon xe-133 (2 trials)

Drugs in Phase 1 Trials (1)

xenon-129 (Xenoview) (4 trials)

Drugs in Other Trials (1)

helium-3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Bronchopulmonary Dysplasia (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 3